Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JUN | P05412 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HBB | P68871 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15401295 | 1.00 | JUN (0.43) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL4010937 | 0.88 | JUN (0.52) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL15401259 | 0.88 | JUN (0.52) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL4010936 | 0.88 | JUN (0.52) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL4004416 | 0.85 | JUN (0.54) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL4004419 | 0.85 | JUN (0.54) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL7476502 | 0.77 | JUN (0.48) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL7476497 | 0.77 | JUN (0.48) | JUNNFKB1SNCANPC1MAPT | |
| SCHEMBL96922 | 0.76 | MAOB (0.70) | NPC1MAPTRAB9ASMN1; SMN2CYP1A2 | |
| SCHEMBL96921 | 0.76 | MAOB (0.70) | NPC1MAPTRAB9ASMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9669115-B2 | Co-crystals and salts of contrast agents and imaging | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2017-06-06 | — | — | US | disclosed |
| US-20140004051-A1 | CO-CRYSTALS AND SALTS OF CONTRAST AGENTS AND IMAGING | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2014-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140004051-A1 | CO-CRYSTALS AND SALTS OF CONTRAST AGENTS AND IMAGING | SLC10A1, RCC2, SSB | JUN 1086/4885NFKB1 2184/4885SNCA 691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.